FDA To Boston Scientific: Stop Selling Pelvic Mesh Tied To Injuries In Women
WASHINGTON (AP) — U.S. health regulators on Tuesday halted sales of a type of surgical mesh used to repair pelvic conditions in women, following years of patients’ reports of injuries and complications from the implants. The Food and Drug Administration ordered the two remaining makers of the mesh — Boston Scientific and Coloplast — to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. Several other major manufacturers, including Johnson & Johnson, previously stopped making the mesh. The FDA action does not apply to surgical mesh used to treat ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Boston Scientific FDA Source Type: news

Balversa Approved for Advanced Bladder Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - April 16, 2019 Category: Cancer & Oncology Source Type: news

Balversa Approved for Advanced Bladder Cancer
MONDAY, April 15, 2019 -- Balversa (rdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cancer caused by a genetic defect called FGFR3 or FGFR2, the agency said in a news... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2019 Category: General Medicine Source Type: news

Balversa (erdafitinib) Approved for Advanced Bladder Cancer
MONDAY, April 15, 2019 -- Balversa (erdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cancer caused by a genetic defect called FGFR3 or FGFR2, the agency said in a news... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2019 Category: General Medicine Source Type: news

FDA approves first targeted therapy for metastatic bladder cancer
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy. (Source: World Pharma News)
Source: World Pharma News - April 15, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Johnson & Johnson wins U.S. FDA approval for bladder cancer drug
Johnson& Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday. (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Okays First Targeted Drug for Metastatic Bladder Cancer FDA Okays First Targeted Drug for Metastatic Bladder Cancer
Accelerated approval was granted to erdafitinib for treating locally advanced or metastatic bladder cancer with genetic alterations FGFR3 or FGFR2 after progressing on chemotherapy. A companion diagnostic was also approved.FDA Approvals (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 13, 2019 Category: Urology & Nephrology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer
April 12, 2019 -- The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 13, 2019 Category: Drugs & Pharmacology Source Type: news

Clovis Oncology halts mid-stage bladder cancer trial, shares drop
Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent. (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Personalized Tx for Metastatic Bladder Cancer
FRIDAY, April 12, 2019 -- The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor (FGFR) genetic alterations was granted accelerated approval by the U.S. Food and Drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2019 Category: Pharmaceuticals Source Type: news

U.S. FDA approves Johnson & Johnson's bladder cancer drug
The U.S. Food and Drug Administration on Friday approved Johnson& Johnson's treatment for patients with a form of bladder cancer. (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first targeted therapy for metastatic bladder cancer
The FDA granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 12, 2019 Category: American Health Source Type: news

Balversa Fast-Tracked for Bladder Cancer
Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration. (Source: CancerNetwork)
Source: CancerNetwork - April 12, 2019 Category: Cancer & Oncology Authors: David Frabotta Source Type: news

NCCN: New Bladder Cancer Guidelines Include Updated Staging, Immunotherapy Options
The updates to the guidelines reflect  recent advances, including recommended immunotherapies and changes in tumor staging. (Source: CancerNetwork)
Source: CancerNetwork - March 29, 2019 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Companies Plan to Submit Biologics License Application Later This Year BOTHELL, Wash. and TOKYO, March 28, 2019 -- (Healthcare Sales & Marketing Network) -- Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: K... Biopharmaceuticals, Urology, Oncology Astellas Pharma, Seattle Genetics, enfortumab vedotin, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 28, 2019 Category: Pharmaceuticals Source Type: news

Active Surveillance for Non-Muscle Invasive Bladder Cancer Active Surveillance for Non-Muscle Invasive Bladder Cancer
What is the current state of knowledge concerning the use of active surveillance for low grade non-muscle invasive bladder cancer?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 26, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Younger Age at Menopause Tied to Higher Risk for Bladder Cancer
Women with menopause onset by age 45 at higher risk than those with onset at age 50 or older (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 22, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Urology, Conference News, Source Type: news

Younger Age at Menopause Tied to Higher Risk for Bladder Cancer
FRIDAY, March 22, 2019 -- An earlier age at menopause is associated with a higher risk for bladder cancer, according to a study presented at the annual meeting of the European Association of Urology, held from March 15 to 19 in Barcelona,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 22, 2019 Category: Pharmaceuticals Source Type: news

Machines Treating Patients? It ’s Already Happening
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - March 21, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news

US Launches First National Firefighter Cancer Registry
The National Institute for Occupational Safety and Health has launched the first nationwide Firefighter Cancer Registry, linking workplace exposures to deadly malignancies such as mesothelioma. Officials administering the study believe the registry will help reduce the incidence of various cancers for firefighters. “A national registry will go a long way toward answering the many questions still out there,” Dr. Kenny Fent, an industrial hygienist at NIOSH who is leading the effort, told The Mesothelioma Center at Asbestos.com. “We’re just laying the groundwork now, but in the long run, we want to h...
Source: Asbestos and Mesothelioma News - March 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Roche to present results of the largest safety study of its kind with Tecentriq (atezolizumab) in patients with metastatic bladder cancer
Roche today announced first results from SAUL, a Phase IIIb study evaluating the safety of Tecentriq ® in approximately 1000 patients with locally advanced or metastatic urothelial carcinoma (mUC) including several clinically relevant populations reflective of real-world clinical practice (patients with renal impairment, poor performance status (ECOG PS 2), treated asymptomatic CNS metastases, sta ble controlled autoimmune disease). (Source: Roche Investor Update)
Source: Roche Investor Update - March 18, 2019 Category: Pharmaceuticals Source Type: news

Mental health state associated with higher death rates for prostate and urological cancers
(European Association of Urology) Patients with prostate, bladder or kidney cancers are at greater risk of dying if they have had psychiatric care prior to the cancer treatment. In addition, patients with these cancers show greater suicide risk than the general population, even once the data is corrected for previous psychiatric care. These are the findings of a study presented at the European Association of Urology congress in Barcelona, highlighting the need for psychiatric care to be integrated into cancer treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2019 Category: International Medicine & Public Health Source Type: news

Early menopause in smokers linked to bladder cancer
Longitudinal data used from over 220,000 nurses Related items fromOnMedica Breast cancer rate falls with decline in HRT use Only a third of women with regular bloating would see their GP Women consider legal action over cancer link breast implants Some irregular cervical lesions could be monitored rather that treated immediately Women who were not offered breast screening have been contacted (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 15, 2019 Category: UK Health Source Type: news

No End in Sight, Bladder Cancer Drug Shortage Takes a Toll No End in Sight, Bladder Cancer Drug Shortage Takes a Toll
The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Concerns mount as worldwide shortage of bladder cancer treatment drags on
Doctors in Alberta, and across the country, are doing what they can to shield patients from a worldwide shortage of a key bladder cancer drug, but there are concerns patients could suffer as the company warns back orders could continue for months. (Source: CBC | Health)
Source: CBC | Health - March 8, 2019 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

‘Devastating' loophole means bladder cancer patients face FIVE MONTH wait for treatment
The Labour Party and charity Fight Bladder Cancer have warned the way the NHS in the UK records bladder cancer tests causes confusion and looks on paper like people have been treated. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2019 Category: Consumer Health News Source Type: news

Mauna Kea Nixes Deal with Cook Medical
Citing a lack of commercial progress, Mauna Kea Technologies is calling off an agreement with Cook Medical that was signed a little over three years ago involving Mauna Kea's Cellvizio platform. Paris, France-based Mauna Kea said the decision to terminate the development and distribution agreements with Cook was mutual. Cook has not officially commented on the news. Cellvizio is a multidisciplinary probe and needle-based confocal laser endoscopy platform. The device enables direct visualization of human tissues at the cellular scale and allows doctors to detect anomalies invisible with standard techniques, part...
Source: MDDI - February 21, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Novel Agent Shows Promise in Advanced'Post-Checkpoint' Bladder Cancer Novel Agent Shows Promise in Advanced'Post-Checkpoint' Bladder Cancer
Investigational agent sacituzumab govitecan showed activity in patients with metastatic urothelial cancer, including some previously treated with immune checkpoint inhibitors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients
Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co's immunotherapy, Opdivo, showed signs of tumor reduction in an early-stage study. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

New Ultrasound Technology Targets Prostate Cancer
EDAP TMS, a global leader in the development of therapeutic ultrasound technologies, recently announced that the company’s flagship technology, known as Focal One, will now be offered at leading medical centers on both the East Coast and West Coast of the United States. The John Wayne Cancer Institute at the Providence Saint John’s Health Center in Santa Monica, CA will offer the technology out west, while Brooklyn, New York’s Maimonides Medical Center will be the first to offer the technology on the East Coast. The new technology uses high intensity focused ultrasound...
Source: MDDI - February 15, 2019 Category: Medical Devices Authors: Kristopher Sturgis Tags: Imaging Source Type: news

Hypofractionated RT should be considered new practice standard for men with low risk prostate cancer
(NRG Oncology) Results from the NRG Oncology clinical study NRG-RTOG 0415 determined that a hypofractionated radiotherapy schedule (H-RT), a treatment schedule that delivers a total dose of radiotherapy over a shorter period of time, is not worse than the conventional radiotherapy schedule (C-RT) in terms of bowel, bladder, sexual, and general quality of life (QOL) as well as anxiety and depression for men with low risk prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2019 Category: Cancer & Oncology Source Type: news

Recurring infections could lead to delayed bladder or kidney cancer diagnosis
(Cancer Research UK) Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs), according to new research presented at Cancer Research UK's Early Diagnosis Conference in Birmingham today (Wednesday). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2019 Category: Cancer & Oncology Source Type: news

Merck Highlights Breadth of Immuno-Oncology Research Program in Genitourinary Cancers at ASCO GU
Merck announced yesterday that new combination and monotherapy data from the company ’s broad immuno-oncology research program in genitourinary cancers – renal, prostate and bladder − will be presented at the 2019 Genitourinary Cancers Symposium (ASCO GU) in San Francisco from February 14-16.02/12/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 12, 2019 Category: Urology & Nephrology Source Type: news

New diagnostic technique reveals a protein biomarker that accurately differentiates bladder cancer from benign inflammation
(Elsevier) Label-free digital pathology using infrared (IR) imaging with subsequent proteomic analysis for bladder cancer (BC) has revealed the first protein biomarker (AHNAK2) for BC. AHNAK2 differentiates between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type BC (carcinoma in situ) which is challenging to diagnose. A report in The American Journal of Pathology describes this new diagnostic procedure, which is label-free, automated, observer-independent, and as sensitive and specific as established histopathological methods. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2019 Category: Cancer & Oncology Source Type: news

Medical News Today: Bladder cancer: What to know about BCG treatment
Bacillus Calmette –Guerin (BCG) treatment can help prevent cancer from returning following surgery for early-stage bladder cancer. Doctors deliver BCG directly to a person’s bladder using a catheter. Learn more about what BCG is, and what to expect during the procedure, here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2019 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Country star Doug Supernaw reveals he is battling stage IV lung and bladder cancer
Country music star Doug Supernaw, 58, was first diagnosed with pneumonia after a persistent cough until further tests revealed cancerous tumors in his lungs, lymph nodes, bones, and bladder (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2019 Category: Consumer Health News Source Type: news

Swimming in chlorinated pools heightens bladder cancer risk by 57%
(Natural News) Swimming is a popular form of both exercise and recreation. It is a low-impact physical activity that doesn’t require intense physical exertion. Swimming, on its own, can provide a number of health benefits, but you should be on the lookout for what kinds of pools you swim in. Swimming in pools that are... (Source: NaturalNews.com)
Source: NaturalNews.com - January 24, 2019 Category: Consumer Health News Source Type: news

23andMe Has a New Genetic Cancer Test. But the Results Don ’t Tell You the Whole Story
Consumer genetics company 23andMe is diving deeper into the medical space. On Jan. 22, the company announced that the Food and Drug Administration (FDA) approved its newest report, which can flag whether people have genetic variants that may raise their risk of developing colorectal cancer. The new test looks for two gene variants associated with MUTYH-associated polyposis, an inherited colorectal cancer syndrome. “If left unchecked, carrying both of these variants or having two copies of one increases the risk of developing colorectal cancer to between 43 and 100 percent,” according to 23andMe. The test will b...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Source Type: news

Medical News Today: What causes bladder pain?
Bladder pain may occur due to interstitial cystitis, a bladder infection, bladder cancer, or kidney stones. In this article, we look at the causes and treatment of bladder pain. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 22, 2019 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Smoking Associated With Worse Bladder Cancer Outcomes
FRIDAY, Jan. 11, 2019 -- Cigarette smoking is linked to a poor response to cisplatin-based neoadjuvant chemotherapy (NAC) among patients with muscle-invasive bladder cancer (MIBC) who undergo radical cystectomy (RC), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2019 Category: Pharmaceuticals Source Type: news

Epidural Anesthesia and Cancer Outcomes in Bladder Cancer Epidural Anesthesia and Cancer Outcomes in Bladder Cancer
Is tumor recurrence after radical cystectomy for bladder cancer associated with the use of epidural opioids?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Cigarette smoking may contribute to worse outcomes in bladder cancer patients
(Wiley) In a study of patients with muscle-invasive bladder cancer who had undergone radical cystectomy, cigarette smoking was linked with poor response to cisplatin-based chemotherapy. Also, current smokers in the study, published in BJU International, were at significantly higher risk of cancer recurrence compared with former and never smokers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2019 Category: International Medicine & Public Health Source Type: news

Cancer symptoms: ALWAYS see a doctor if you notice this when you go to the toilet
CANCER symptoms vary between the different types of cancer, but some types share common signs. If you notice this symptom when you go to the toilet, always see a doctor as it could be a sign of prostate, bladder or kidney cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - January 8, 2019 Category: Consumer Health News Source Type: news

Prostate cancer symptoms: These toilet habits could be a sign of the disease
PROSTATE cancer symptoms typically involve problems with urinating, but how do you know if your toilet habits are a sign of the disease? These are the bladder changes to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - January 4, 2019 Category: Consumer Health News Source Type: news

Breath Test To Detect Multiple Cancers Early Begins Large Trial
(CNN) — A breathalyzer designed to detect multiple cancers early is being tested in the UK. Several illnesses are known to create signature smells from the body, including typhoid fever reported to smell like baked bread and the aroma of acetone, said to be similar to rotten apples, on the breath of diabetics. Recent research has also shown that a person’s breath could also indicate the presence of cancer. To test this theory, Cancer Research UK have launched a two-year trial into a clinical device, called the Breath Biopsy, to find out if exhaled airborne molecules can be useful for cancer detection. (Image cr...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 3, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer CNN Local TV Source Type: news

Bladder Cancer | Medscape Bladder Cancer | Medscape
Bladder cancer is the second most common urologic malignancy. Transitional cell carcinoma accounts for more than 90% of cases; other types include squamous cell carcinoma and adenocarcinoma. In stage 1 disease, when the tumors are superficial, bladder cancer is treatable with transurethral resection and intravesical therapy. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

Halve your chances of dying from cancer by supplementing with selenium
(Natural News) You can prevent cancer naturally by taking selenium supplements. Many studies have reported that selenium protects you from prostate cancer and colorectal cancer — two of the most common forms of cancer. Selenium deficiency has been linked to two to three times increase in overall cancer risk, particularly bladder, esophagus, lung, stomach, and liver cancers.... (Source: NaturalNews.com)
Source: NaturalNews.com - December 28, 2018 Category: Consumer Health News Source Type: news

Incontinence Drug May Help Ease Severe Hot Flashes
Oxybutynin, a drug widely used to treat urinary incontinence caused by an overactive bladder, helps treat hot flashes in breast cancer survivors and women who did not have breast cancer but who were bothered by frequent or severe menopausal symptoms, new research shows. (Source: WebMD Health)
Source: WebMD Health - December 17, 2018 Category: Consumer Health News Source Type: news

Actos, a commonly prescribed drug for diabetes, can give you bladder cancer
(Natural News) The drug pioglitazone (brand name Actos) can allegedly help control and regulate blood sugar in people with type 2 diabetes. However, the results of a study have revealed that some patients with diabetes who used the toxic drug eventually developed bladder cancer. The study was published in The British Medical Journal (BMJ). The deadly side effects of Actos... (Source: NaturalNews.com)
Source: NaturalNews.com - December 14, 2018 Category: Consumer Health News Source Type: news